Accelerator mass spectrometry-enabled studies: current status and future prospects.
Accelerator mass spectrometry is a detection platform with exceptional sensitivity compared with other bioanalytical platforms. Accelerator mass spectrometry (AMS) is widely used in archeology for radiocarbon dating applications. Early exploration of the biological and pharmaceutical applications of AMS began in the early 1990s. AMS has since demonstrated unique problem-solving ability in nutrition science, toxicology and pharmacology. AMS has also enabled the development of new applications, such as Phase 0 microdosing. Recent development of AMS-enabled applications has transformed this novelty research instrument to a valuable tool within the pharmaceutical industry. Although there is now greater awareness of AMS technology, recognition and appreciation of the range of AMS-enabled applications is still lacking, including study-design strategies. This review aims to provide further insight into the wide range of AMS-enabled applications. Examples of studies conducted over the past two decades will be presented, as well as prospects for the future of AMS.
Arjomand
Ali
A
Accium BioSciences, Inc., James Tower Life Sciences, Building, 550 17th Avenue, Suite 550, Seattle, Washington 98122, USA. arjomand@acciumbio.com
D053000:Analytic Sample Preparation Methods; D000818:Animals; D055808:Drug Discovery; D006801:Humans; D013058:Mass Spectrometry / Q000295:instrumentation / Q000379:methods* / Q000639:trends*; D049329:Nanostructures / Q000032:analysis / Q000737:chemistry; D052756:Nutritional Sciences; D014116:Toxicology